2008Northwest Pharmaceutical JournalRequires access

Study on pharmacokinetics and relative bioavailabity of nimesulide orally disintegrating tablets

Gu Yi

Open publisher page 0 citations

Abstract

Objective To study the relative bioavailability and the phamacokinetics of nimesulide orally disintegrating tablets.Method A single oral administration 200 mg of nimesulide orally disintegrating tablets were given in 20 healthy male volunteers divided into two groups according to randomized crossover design.Nimesulide concentrations in plasma were determined by HPLC.The pharmacokinetic parameters and relative bioavailability of tested tablets were calculated and compared with that of reference tablets.Result After a single oral administration 200 mg of orally disintegrating tablets and reference tablets,the obtained pharmacokinetic parameters were as follows :t1/2(3.626±1.098)h and(3.369±0.55)h;tmax(3.70±0.80)h and(3.55±0.76)h;Cmax:(8.47±1.86)mg·L-1 and(8.55±2.41)mg·L-1;AUC0~16 h(56.90±12.58)mg·h·L-1 and(54.63±17.35)mg·h·L-1.respectively.The relative bioavailability of tested tablets was 106.62%.No significant differences were found among the main pharmacokinetic parameters(P0.05).Conclusion The two preparations presented bioequivalent.

About this research paper

What this paper is about

Objective To study the relative bioavailability and the phamacokinetics of nimesulide orally disintegrating tablets.Method A single oral administration 200 mg of nimesulide orally disintegrating tablets were given in 20 healthy male volunteers divided into two groups according to randomized crossover design.Nimesulide concentrations in plasma were determined by HPLC.The pharmacokinetic parameters and relative bioavailability of tested tablets were calculated and compared with that of reference tablets.Result After a single oral administration 200 mg of orally disintegrating tablets and reference tablets,the obtained pharmacokinetic parameters were as follows :t1/2(3.626±1.098)h and(3.369±0.55)h;tmax(3.70±0.80)h and(3.55±0.76)h;Cmax:(8.47±1.86)mg·L-1 and(8.55±2.41)mg·L-1;AUC0~16 h(56.90±12.58)mg·h·L-1 and(54.63±17.35)mg·h·L-1.respectively.The relative bioavailability of tested tablets was 106.62%.No significant differences were found among the main pharmacokinetic parameters(P0.05).Conclusion The two preparations presented bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the relative bioavailability and the phamacokinetics of nimesulide orally disintegrating tablets.Method A single oral administration 200 mg of nimesulide orally disintegrating tablets were given in 20 healthy male volunteers divided into two groups according to randomized crossover design.Nimesulide concentrations in plasma were determined by HPLC.The pharmacokinetic parameters and relative bioavailability of tested tablets were calculated and compared with that of reference tablets.Result After a single oral administration 200 mg of orally disintegrating tablets and reference tablets,the obtained pharmacokinetic parameters were as follows :t1/2(3.626±1.098)h and(3.369±0.55)h;tmax(3.70±0.80)h and(3.55±0.76)h;Cmax:(8.47±1.86)mg·L-1 and(8.55±2.41)mg·L-1;AUC0~16 h(56.90±12.58)mg·h·L-1 and(54.63±17.35)mg·h·L-1.respectively.The relative bioavailability of tested tablets was 106.62%.No significant differences were found among the main pharmacokinetic parameters(P0.05).Conclusion The two preparations presented bioequivalent.

Key concepts: Nimesulide, Bioequivalence, Bioavailability, Pharmacokinetics, Cmax, Pharmacology, Chemistry, Oral administration

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on pharmacokinetics and relative bioavailabity of nimesulide orally disintegrating tablets — Research Paper | ScholarLens